Xencor (XNCR) Other financing activities (2014 - 2026)
Xencor's (XNCR) quarterly Other financing activities came in at $950000.0 in Q1 2026, down 68.06% year-on-year from $3.0 million in Q1 2025, and down 88.13% on a QoQ basis from $8.0 million in Q4 2025.
Xencor (XNCR) Other financing activities (2014 - 2026) Analysis & Trends
Xencor (XNCR) has 13 years of Other financing activities data on file, last reported at $950000.0 in Q1 2026.
- On a quarterly basis, Other financing activities fell 68.06% year-over-year to $950000.0 in Q1 2026; TTM through Mar 2026 was $6.6 million, a 459.65% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $950000.0, down from $8.0 million in the prior quarter.
- Over the last five years, Other financing activities for XNCR reached as high as $8.0 million in Q4 2025 and fell as low as -$2.3 million in Q3 2025.
- Historically, Other financing activities has averaged $1.1 million across 5 years, with a median of $922000.0 in 2023.
- Across the five-year window, Other financing activities sank 367.81% in 2024 and surged 960.75% in 2025, its largest moves.
- Year by year, Other financing activities stood at $276000.0 in 2022, then soared by 427.17% to $1.5 million in 2023, then sank by 163.92% to -$930000.0 in 2024, then jumped by 960.75% to $8.0 million in 2025, then sank by 88.13% to $950000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $950000.0 in Q1 2026, $8.0 million in Q4 2025, and -$2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 950,000.00 |
| Mar 31, 2026 | 950,000.00 |
| Dec 31, 2025 | 8.01 Mn |
| Dec 31, 2025 | 8.01 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Sep 30, 2025 | -2.31 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | -930,000.00 |
| Dec 31, 2024 | -930,000.00 |
| Jun 30, 2024 | -857,000.00 |
| Jun 30, 2024 | -857,000.00 |
| Mar 31, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 715,000.00 |
| Sep 30, 2023 | 715,000.00 |
| Jun 30, 2023 | 320,000.00 |
| Jun 30, 2023 | 320,000.00 |